• Merck and IFEZ ink MoU for expanding investment biospectrumasia
    January 24, 2018
    The agreement was made between Merck Korea Managing Director Glenn Young and IFEZ Commissioner Kim Jin-yong, under which Merck will invest 22.1 billion won ($20.5 million) in the cluster.
PharmaSources Customer Service